New award for teriflunomide tablets with avkare LLC. Period of performance is DEC 23, 2023 to DEC 22, 2024 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79724D0004
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 95% complete
IDV ceiling
$995,714.50
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The VA National Acquisition Center awarded an indefinite-delivery contract to Avkare LLC on December 23, 2023, for teriflunomide tablets with a ceiling of $995,714.50 as a single-award procurement carrying no set-aside restriction.

The contract covers supply of teriflunomide 14 mg tablets (estimated annual requirement 11,883 bottles) and teriflunomide 7 mg tablets (estimated annual requirement 1,508 bottles) for uninterrupted distribution through the VA and DOD pharmaceutical prime vendor programs, serving the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Place of performance is Pulaski, Tennessee.

The period of performance runs from December 23, 2023, through December 22, 2024, with four one-year option periods. The originating RFP, posted August 8, 2023, with a closing date of September 5, 2023, required offerors to ensure uninterrupted supply of contracted items and comply with solicitation requirements and regulations. The solicitation was issued on an unrestricted, full-and-open basis under Federal Acquisition Regulation Part 12 commercial items procedures. A modification was issued to incorporate Executive Order 14398 DEI discrimination requirements into the national contract award record.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · This modification is issued to incorporate EO 14398 DEI discrimination into national contract 36E79724D0004. $0
Add Subcontract Plan P00006 · This modification is issued to incorporate avkare, LLC 2026 subcontracting plan into national contract 36E79724D0004. $0
Exercise an Option P00005 · This modification is issued to exercise the 2ND option year for teriflunomide tablets under national contract 36E79724D0004. $0
Add Subcontract Plan P00004 · This modification is issued to incorporate avkare, LLC 2025 subcontracting plan into contract 36E79724D0004. $0
Exercise an Option P00003 · This modification is issued to exercise the 1ST option year for teriflunomide tablets under contract 36E79724D0004 with avkare LLC. $0
Supplemental Agreement for work within scope P00002 · This modification is issued to update the terms of the CRF payment remittal and submission of quarterly sales reports. $0
Add Subcontract Plan P00001 · This modification is issued to incorporate avkare, LLC 2024 subcontracting plan for the period of january 1, 2024 -- december 31, 2024. $0
Original award $0

Quick answers

Who was awarded contract 36E79724D0004?

36E79724D0004 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on December 23, 2023.

How much is contract 36E79724D0004 worth?

36E79724D0004's own ceiling is $995,715.

Who can order from contract 36E79724D0004?

36E79724D0004 is a single award indefinite delivery contract.

Was contract 36E79724D0004 competed?

The extent of competition for 36E79724D0004 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV